Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gastroesophageal Cancer × Nivolumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 50 Carcinoma, Non-Small-Cell Lung 45 Carcinoma, Renal Cell 32 Neoplasms 24 Neoplasm Metastasis 21 Colorectal Neoplasms 20 Carcinoma, Hepatocellular 19 Squamous Cell Carcinoma of Head and Neck 17 Stomach Neoplasms 15 Triple Negative Breast Neoplasms 14 Ovarian Neoplasms 14 Lung Neoplasms 11 Pancreatic Neoplasms 10 Hodgkin Disease 10 Carcinoma, Transitional Cell 10 Head and Neck Neoplasms 8 Small Cell Lung Carcinoma 7 Sarcoma 7 Recurrence 7 Urinary Bladder Neoplasms 6 Prostatic Neoplasms 6 Lymphoma, Non-Hodgkin 6 Endometrial Neoplasms 6 Carcinoma, Merkel Cell 6 Breast Neoplasms 6 Advanced Cancer 6 Uterine Cervical Neoplasms 5 Glioblastoma 5 Colonic Neoplasms 5 Uveal Melanoma 4

Interventions

relatlimab 1 Nivolumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610711 2025-12-22

REACTION

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting

Gastrointestinal

Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡